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SUMMARY 
This degree project has been performed as a Minor Field Study (MFS) in Tanzania, investigating the 
seroprevalence in goats and sheep of three diseases causing similar signs as peste des petits ruminants 
virus (PPRV): foot and mouth disease (FMD), bluetongue (BT) and contagious caprine 
pleuropneumonia (CCPP), as well as bovine viral diarrhoea (BVD) and border disease (BDV) which is 
believed to affect an outbreak of PPR due to immunosuppression. Sheep and goats play a key role in 
national food and nutritional security, income security and livelihood resilience in the least 
economically developed countries across the world and because of the complicated epidemiology and 
socio-economic impact of these diseases it is of great interest to further evaluate the prevalence of 
PPRV and its differential diagnosis. 
In this study blood samples were collected from 483 goats and sheep. Samples from a previous MFS 
done in 2014 were also analysed. The sampled animals came from three different regions in south-
eastern Tanzania and the seroprevalence of FMD, BT, CCPP and BVDV was investigated by tracing 
antibodies in serum by competitive ELISA. The seroprevalence differed highly between the diseases. 
BTV had the highest seroprevalence with a total seroprevalence of 67.0%, while BVDV had the 
lowest with a total seroprevalence of 2.9%. The total seroprevalence of FMD was 26,5% and CCPP 
19.0%.  
The results in this study show that FMDV, BTV, BVDV and CCPP are serologically present in 
southern Tanzania. These diseases are likely circulating and endemic in the area but the importance of 
the different diseases varies because of the differing levels of severity and consequences for farmers. 
FMD and CCPP are relevant differential diagnoses to PPR and should be taken into consideration 
when working to prevent, and in longer term, eradicate PPRV. The risk of mistaking PPR for BT and 
vice versa appears to be very low at the moment considering these diseases do not appear to cause 
similar clinical signs as PPR in Tanzanian sheep and goats. 
SAMMANFATTNING 
Detta examensarbete har genomförts som en Minor Field Study (MFS) i Tanzania med målet att 
undersöka seroprevalensen av tre utvalda differentialdiagnoser till PPR hos får och getter: mul och 
klövsjuka (FMD), bluetongue (BT) och smittsam pleuropneumoni (CCPP). Även bovin virusdiarré 
(BVD) och border disease ingick i studien då denna sjukdom sannolikt kan påverka utbrott av PPR 
genom immunosuppression. Får och getter har en mycket viktig roll i att säkra mattillgång, ekonomisk 
stabilitet och möjlighet till uppehälle i många av världens minst ekonomiskt utvecklade länder. PPR 
och vissa av sjukdomens differentialdiagnoser kan ha stora konsekvenser och orsaka stort ekonomiskt 
lidande och av den anledningen är det av intresse att fortsätta undersöka dessa sjukdomars 
epidemiologi och socio-ekonomiska påverkan. 
I denna studie samlades blod från 483 får och getter från tre olika regioner i sydöstra Tanzania. Även 
prover från tidigare Minor Field Studies (Wensman et al., 2015) analyserades. Seroprevalensen av 
FMD, BT, CCPP och BVD undersöktes i serum genom att använda kompetitiv ELISA. 
Seroprevalensen av de olika sjukdomarna varierade kraftigt. Den högsta seroprevalensen var av BT 
med en total seroprevalens på 67.0% medan BVD hade den lägsta totala seroprevalensen på 2.9%. 
Den totala seroprevalensen av FMD och BVD var 26.5% respektive 19.0%. 
Resultaten i denna studie påvisar att antikroppar mot FMDV, BTV, BVDV och Mycoplasma 
capricolum subsp.capripneumoniae (Mccp) finns hos får och getter i sydöstra Tanzania där tama och 
vilda djur har kontakt. Sjukdomarna cirkulerar bland får och getter och är troligtvis endemiska. 
Betydelsen av de olika sjukdomarna varierar beroende på hur allvarliga konsekvenser insjuknande av 
djur har för djurägaren. CCPP och FMDV kan anses vara relevanta differentialdiagnoser till PPR och 
bär tas i beaktande när man arbetar för att förebygga och bekämpa PPR. Risken att BT misstas för 
PPR eller vice versa kan anses vara liten eftersom BT inte verkar orsaka likartade symptom som PPR 
hos får och getter i Tanzania. 
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1 
INTRODUCTION 
Aims 
The purpose of this study was to evaluate the seroprevalence of three three diseases belonging to the 
differential diagnosis to Peste des Petits ruminants virus (PPR): foot and mouth disease (FMD), 
bluetongue (BT) and contagious caprine pleuropneumonia (CCPP). In addition, sero-prevalence of 
bovine viral diarrhoea (BVD) and border disease (BD), that likely can affect an outbreak of PPR due 
to immunosupression, was investigated.  
Peste des petits ruminant is a contagious disease that affects small ruminants like sheep and goats in 
Africa, the Middle East and parts of Asia. The disease is caused by the morbillivirus Peste des petits 
ruminants virus (PPRV). PPRV is closely related to Rinderpest virus, which today is eradicated from 
the world. PPRV has been identified as one of the next targets for eradication, but there are still some 
knowledge gaps to be filled before successful eradication schemes can be implemented (FAO, 2013). 
For example, the role of wildlife in the epidemiology and virus transmission needs to be clarified 
(Munir, 2013).  
The importance of the exchange of PPR and some of the diseases which cause similar signs between 
livestock and wildlife in Tanzania is today uncertain. Wildlife could play an important role in the 
epidemiology of these pathogens since wildlife and livestock often live side by side. The prevalence of 
PPR and its differential diagnoses like foot and mouth disease (FMD), bluetoungue (BT) and 
contagious caprine pleuropneumonia (CCPP) is not determined, therefore it is of interest to do a 
serologic screening of small ruminants in this area. 
The pathogens selected for this study could present clinical signs similar to those of PPR, for example 
FMD where the most common feature of both infections is lesions in the mouth (Munir et al., 2013). 
FMD lesions are very small and do not occlude the oral cavity. Neither do these lesions cause a foul 
smell in the affected animals, whereas in PPR the oral lesions are prominent and can create hindrance 
in feed intake. Another similar disease is BT, which also causes pyrexia and lesions in the mouth. 
CCPP and PPR share some clinical signs, such as difficult breathing and coughing, but oral lesions 
and diarrhea are not present in CCPP (Munir et al., 2013).  Co-infections with multiple pathogens 
could affect the severity of clinical signs and clinical outcome of a PPR outbreak. PPR, FMD, BT and 
CCPP cause major economic losses in affected countries. First of all because the high lethality rate 
among small ruminants leads to a decrease in the amount of food, but also because the diseases 
obstruct trade and transportation of animals. Most of the countries having problems with these 
diseases are low- or middle-income countries. Since small ruminants are the only income for many 
families in these countries, the diseases above inhibit the development in a wider perspective and 
consequently prevent the fight against poverty in the world. This study is a smaller part of a three-year 
project, which is a collaboration between Sweden, Pakistan, Tanzania and the UK, funded by the 
Swedish Research Council (VR U-forsk). The aim of the large project is to study the prevalence of 
PPRV in wild and domestic small ruminants in the wildlife-livestock interface to evaluate the role of 
wildlife in the epidemiology of the disease and virus transmission.  The work done in this study will 
contribute to the larger project by collecting data by fieldwork, performing lab work and data analysis. 
Study region 
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Tanzania is a country in East Africa with 26 different regions and a population of almost 45 million 
people on 945 203 km2. The country is famous for its rich nature and wildlife. Agriculture is the most 
important sector and is estimated to be 25 % of the gross domestic products (National Bureau of 
Statistics, Tanzania Ministry of Finance, 2014). The sampling for this study was done in three districts 
in the Morogoro region. The region is located in south eastern Tanzania and has an average 
temperature that differs between 18.6°C- 30°C and the average annual precipitation is 935 mm 
(Climatedata, 2015). Morogoro is the centre for agricultural sciences in the country. The three sampled 
districts were Kilombero, Ulanga and Mvomero. Agro-pastoral farming is practiced in all of these 
areas. In Ulanga district the sampling was done during two different field studies, one in 2014 
(Wensman et al., 2015) and this one in 2015. In 2014 it was mainly the villages Tanga, Lupunga and 
Mwaya who were sampled, while in 2015 it was the villages Mbuyuni, Kivukoni, Ipera Asikia, 
Lukande and Mbuga. Because the two samplings in Ulanga were done during different years and with 
slightly different groups of animals being targeted, the samples from 2015 will be referred to as 
Ulanga (2015) and the samples from 2104 as Ulanga (2014) in this paper. These specific study areas 
were chosen for several reasons. First of all, to get a broad perspective of the current seroprevalence of 
PPRV (as part of another degree project by Nils Roos to be published in 2016), FMDV, BTV, BVDV 
and CCPP in southern Tanzania. Secondly, all of these regions practice pastoral farming and have a 
large number of small ruminants. Thirdly, to be able to sample small domestic ruminants living in 
close contact with wild animals.  
Figure 1. The coloured dots show the three study areas. 
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LITERATURE REVIEW 
CCPP 
Contagious caprine pleuropneumonia is a severe infectious disease that affects goats, sheep and wild 
ruminants. It occurs in many countries in Africa and Asia and is caused by Mycoplasma 
capricolum subsp.capripneumoniae (Mccp) (OIE 2015). The disease was first reported in Algeria in 
1873, as reviewed by Thiaucourt & Bölske (1996) but the importance and distribution of this disease 
Figure 2. Examples of animal husbandry in Kilombero and Ulanga. 
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remain largely unknown. The causal agent of CCPP was first isolated in 1976 (MacOwan et al., 1976), 
but it was not given its species name M. capricolum subsp. Capripneumoniae (Mccp) until 1993 
(Leach et al., 1993).  There have been very few declarations of outbreaks of the disease to the OIE in 
the last 15 years, perhaps due to a lack of awareness of the disease and confusion with other diseases, 
such as “Peste des petits ruminants” (PPR) or Pasteurella infections (Peyraud et al., 2014). 
Etiology 
Mycoplasma capricolum subsp. capripneumoniae (Mccp) belongs to the so called Mycoplasma 
mycoides cluster, which is a group of mycoplasma of particular importance in veterinary medicine. 
Members of this cluster are biochemically and antigenically closely related which makes it difficult to 
diagnose the diseases caused by them (OIE, 2015). Pleuropneumonia in goats is caused by three 
different mycoplasmes; Mycoplasma mycoides subsp. capri, Mycoplasma mycoides subsp. Mycoides 
LC and Mycoplasma capricolum subsp. capripneumoniae. However, only Mccp causes the classical 
contagious caprine pleuropneumonia (OIE, 2015). 
Epidemiology 
Goats were thought to be the only susceptible host for Mccp (Litamoi et al., 1990) but it has been 
reported that sheep can be infected and seroconvert after mixing with affected goats. Mccp has also 
been isolated from healthy sheep and they may function as a reservoir (Thiaucourt and Bölske, 1996, 
Houshaymi et al., 2002). There have been confirmed cases from Qatar of CCPP in wild captive 
ungulates including wild goat, Nubian ibex, Larisstan mouflon and gerenuk with significant morbidity 
and mortality in these species (Arif et al., 2007). 
Outbreaks of CCPP follow the introduction of an infected animal or animals into a susceptible herd. 
The mycoplasma is transmitted over short distances through the expulsion of infected droplets during 
coughing. The disease is very readily contagious, and only brief periods of contact are necessary for 
successful transmission (Bölske et al., 1996).  
No evidence of indirect transmission has been shown as the mycoplasma is highly fragile in the 
environment. As with many mycoplasma diseases such as contagious bovine pleuropneumonia, the 
disease is introduced into a region by asymptomatic carrier animals (OIE, 2015). 
 
Clinical signs and diagnostics 
Goats of all ages and sex can be affected with CCPP (Thiaucourt and Bölske, 1996). The acute disease 
is more noticeable in naive populations in newly affected areas with high mortality and morbidity 
rates. The disease is characterized by cough, severe respiratory distress, pyrexia (40.5–41.5 °C), nasal 
discharge, which is catarrhal at the beginning and becomes muco-purulent in the later stage of disease. 
In chronic cases, the nasal discharges become thick and pasted on the nostrils. At this stage, animals 
show sporadic coughing, emaciation and diarrhea (Radostitis et al. 2006).  In the terminal stages, the 
goats are unable to move and death follows quickly. In subacute or chronic forms, signs are milder 
with coughing usually noticeable only following exercise. High mortality can be seen in kids as a 
result of septicaemia (Nicholas and Churchward, 2012). Typical findings at post-mortem examination 
are fibrinous pleuropneumonia with massive lung hepatisation and pleurisy, accompanied by 
accumulation of straw-coloured pleural fluid (Thiaucourt and Bölske, 1996).  
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Definite diagnosis of M. capricolum subsp. capripneumoniae infection requires culture of the 
causative organism from lung tissue samples and/or pleural fluid taken at post-mortem, although high 
mortality and typical early thoracic lesions in goats are highly indicative of the disease. Isolates can be 
identified by several biochemical, immunological and molecular tests (OIE, 2014). Polymerase chain 
reaction based tests can be applied directly to clinical material such as lung and pleural fluid and have 
been shown to be a specific and sensitive test (Bashiruddin et al., 1994, Hotzel et al., 1996). 
Serology has not been widely applied to identify the cause of outbreaks of pleuropneumoniae in goats 
and sheep. This is due to the fact that acute cases caused by Mccp rarely show positive titres before 
death and occurrence of false positive results. For this reason, serologic tests are best used on a herd 
basis rather than for diagnosis in individual animals. The serologic tests that are currently available 
according to OIE are complement fixation, passive hemagglutination, and ELISA. The latex 
agglutination test can be done in the field directly on whole blood as well as on serum samples in the 
laboratory. Serologic cross-reactions may occur with other members of the Mycoplasma mycoides 
cluster (OIE, 2014). 
Foot and mouth disease 
History 
Foot and mouth disease (FMD) is a highly contagious viral disease of domestic and wild cloven-
hoofed (even-toed) animals. It is characterized by fever and vesicles on skin and mucous membranes, 
usually in the mouth and on the muzzle, hooves and teats (Radostitis et al. 2006). The first 
documentation of FMD in Tanzania was in 1927 (Kivaria 2003) and the disease is considered endemic 
in the country. Since the first documentation many outbreaks have occurred in Tanzania, affecting 
almost every region. The first virus type isolation was done in 1957 and out of the seven known sero-
types of FMD, four have been found in Tanzania (type O, type A, SAT-1 and SAT-2) (Kasanga et al., 
2012). 
The clinical signs of FMD are less severe in small ruminants compared to cattle and intensively reared 
pigs and therefore the disease is often ignored or misdiagnosed in small ruminants (Radostitis et al., 
2006). Goats and sheep are often not vaccinated against FMD which makes it possible for them to 
serve as reservoirs for further infection and spread of the disease. However, since FMD has previously 
been controlled in certain areas without vaccinating small ruminants, it is unlikely that small 
ruminants play a large role to the epidemiology of the disease (Anderson et al., 1976, Casas 1984). 
The virus 
Foot and mouth disease virus (FMDV) is classified within the Aphthovirus genus as a member of the 
Picornaviridae family (Belsham 1993), being a non-enveloped, icosahedral virus, 26 nm in diameter, 
containing positive sense RNA of around 8.4 kb. During intracellular, cytoplasmic replication, viral 
RNA is translated into a polyprotein that is proteolytically cleaved into 12 structural and non-structural 
proteins. The complete viral capsid consists of 60 copies of each of the four structural proteins VP1-4, 
with many critical determinants for infection and immunity inherent in the molecular constituents of 
the VP1 protein (Alexandersen et al., 2003). There are seven immunologically distinct serotypes of 
FMDV: A, O, C, SAT1, SAT2, SAT3, and Asia1 which do not confer cross immunity. New FMD 
variants are generated by mutation from error-prone RNA replication, recombination, and host 
selection. (Davies 2002, OIE 2014) 
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Epidemiology 
FMDV has many features, such as a wide host range, an ability to infect in small doses, a high level of 
viral excretion and multiple modes of transmission, which make it a difficult and expensive disease to 
control and eradicate (OIE 2014). 
Transmission of FMD can occur by direct contact between infected and susceptible animals, direct 
contact of susceptible animals with contaminated inanimate objects (hands, footwear, clothing, 
vehicles, etc.), feeding of untreated contaminated meat products, ingestion of contaminated milk by 
calves, artificial insemination with contaminated semen, inhalation of infectious aerosols and airborne 
(OIE 2014). 
It has long been debated if FMDV after the acute stage of infection can cause a prolonged, 
symptomless, persistent infection in ruminants. Carriers (defined as an animal from which the virus 
can be recovered 28 days or more after infection) have been recorded in cattle (Van Bekkum et al 
1959), African buffalo (Hedger and Condy 1985), sheep (Burrows 1968), and goats but not in pigs. It 
occurs with all serotypes and has been identified in both experimentally and naturally infected animals 
(Van Bekkum et al 1959, Hedger 1968). The carrier period appears to vary between species, being in 
excess of 12 months in cattle, up to 9 months in sheep and goats and at least 5 years in African Buffalo 
(Condy et al., 1985). Although there is substantial evidence of carrier animals it is unclear if these 
carriers can transmit the disease to other animals (OIE 2014). 
 
Clinical signs and diagnostics 
The incubation period for FMD is 2–14 days, depending on the infecting dose, susceptibility of the 
host and strain of virus. The clinical picture differs between species and is generally more severe in 
cattle and pigs who develop fever up to 41°C, anorexia, vesicles in the mouth and on the feet as well 
as causing significant drop in milk yield from the herd (OIE, 2014). In sheep and goat the symptoms 
are milder and can be easy to miss as sudden inset of severe lameness may be the only clinical sign of 
disease in a herd. Vesicles are most commonly seen on the coronary band and the interdigital cleft of 
the feet and only sometimes in the mouth (Radostitis et al. 2006). The mortality of FMD is generally 
less than 5%, however, there is a higher mortality in young lambs, kids, calves and piglets due to 
virus-induced damage to the developing cells of the myocardium (Radostitis et al., 2006, OIE 2014). 
Diagnosis is done by analyzing fluid samples from vesicular lesions. Virus can be detected using 
antigen-ELISA, cultivation or RT-PCR. “Pen-side” for diagnostics in the field are under development 
but have not yet been approved by OIE. Serology can be used for later stages of the infection and for 
surveillance of the disease (Alexandersen et al., 2003) 
 
Bluetongue virus 
History 
Bluetongue (BT) is an insect-borne virus disease of ruminants characterised by fever, hyperaemia and 
oedema of the oral region and muzzle, and rawness and reddening of the coronary band. The clinical 
signs vary from inapparent or mild to acute (Howell, 1963; Erasmus, 1975; Hourrigan and Klingsporn, 
1975).  
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BT was first recorded at the end of the 19th century in South Africa (Spreull, 1905). Since then 
Bluetongue virus (BTV) has been isolated from ruminants and/or vector insects from all continents 
except Antarctica (Gibbs E.P. & Greiner E.C., 1994). 
The virus 
Bluetongue virus is a member of the Orbivirus genus in the Reoviridae family. It is similar in 
morphology to other orbiviruses, such as African horse sickness and epizootic hemorrhagic disease 
virus. So far 27 BTV serotypes have been identified world-wide (Roy and Noad, 2006, Schwartz-
Cornil et al., 2008, Jenckel et al. 2015). BTV is a non-enveloped virus, 90 nm in diameter, with a 
triplelayered icosahedral protein capsid (Roy 2008). Its genome consists of ten double-stranded RNA 
segments coding for seven structural proteins (VP1-VP7) and four non-structural proteins (NS1-NS3 
and NS3A) (Kar et al., 2007; Roy, 2008). BTV serotypes 1, 2, 3, 4, 6, and 10 have a high pathogenic 
index and high epidemic potential (Dungu, Gerdes T, Smit T, 2004). However, a high genetic diversity 
of BTV exists that is a consequence of both drift (i.e., point mutations) and shift (i.e., reassortment of 
individual BTV gene segments) so pathogenicity even within a serotype may be highly variable 
(Saegerman C, Hubaux M, Urbain B, Lengelé L, Berkvens D, 2007). 
Epidemiology  
Bluetongue virus is transmitted between animals by haematophagous insects of the genus Culicoides. 
BTV multiplies in the ruminant host and is found in the blood and blood cells. On biting the host, the 
Culicoides vector ingests infected blood. The virus penetrates the gut wall of the midge and multiplies 
in the tissues. After 7 days the midge can infect a new host when taking a blood meal (Sellers 1984). 
Culicoides midges are found in many places in the world but only around 50 out of the 1500 known 
species of Culicoides can transmit the virus to ruminants. The global distribution of BTV is therefore 
restricted to those regions where these vector species of Culicoides occur and its transmission period is 
limited to the times when adult vectors are active. Activity is positively correlated with temperature 
and the optimal temperature for spread of the disease is between 28°C and 30°C (Wilson and Mellor, 
2009). 
Due to the seasonality of the vector’s presence, transmission of the virus was believed to be limited to 
the warmer months of the year. However, recent evidence from California indicated the possibility that 
the virus can survive through the winter in long-living C. soronensis female midges, which had been 
infected during the previous flying activity period (Mayo et al., 2014). BTV can infect a broad 
spectrum of domestic and wild ruminants but serious clinical signs have been observed only in certain 
breeds of sheep (improved breeds) and a few deer species (MacLachlan 1994, Taylor 1986). Because 
cattle and goats usually only develop subclinical infections, they may serve as important and 
concealed viral reservoirs for sheep (MacLachlan 1994). However, some serotypes such as serotype 8, 
which has caused infection in northern Europe, exhibit a more important virulence in cattle (Guyot et 
al, 2007, Thiry et al., 2006) with serious socioeconomic consequences (Saegerman et al., 2007). 
Wild ruminants are considered to function as a potentially important reservoir for virus and vector 
maintenance and a new hypothesis suggesting that two disease cycles exists, one prevalent in wild and 
one in domestic ruminants has been recently proposed (Ruiz-Fons et al., 2014). 
Clinical signs and diagnostics 
Bluetongue virus infects domesticated or wild ruminant species. Clinical manifestations of bluetongue 
vary widely between different animal species, as well as virus strains. Often, the infection remains 
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subclinical. The most serious symptoms are seen in breeds of improved sheep (Kahn and Line, 2010). 
Animals may exhibit disease with initial high fever and depression, followed by hyperaemia of the 
buccal and nasal mucosa, increased salivation, oral discharge and nasal discharge. These signs may be 
accompanied by oedema of the tongue, lips, face, eyelids and ears. Lameness due to hyperaemia of the 
coronary bands and haemorrhages around the hoofs is common. Additionally, pregnant animals may 
abort. Severe swelling of the tongue, which can become cyanotic (‘blue tongue’), has given name to 
the disease but is not a common symptom. In acute cases of disease, animals may die within ten days 
of infection, mainly due to pulmonary oedema (Verwoerd and Erasmus, 2004 and Darpel et al., 2007). 
A preliminary diagnosis of BT can be made based on typical clinical signs and post mortem findings, 
especially in areas where the disease is endemic (Afshar, 1994). Laboratory confirmation of BT is 
based on identification of viral RNA by PCR or on virus isolation in embryonated chicken eggs or 
mammalian and insect cell cultures. The identity of isolates may be confirmed by 
immunofluorescence, immunoperoxidase, serotype-specific virus neutralization tests, serotype-
specific PCR, or hybridization with complementary gene sequences of group- or serotype-specific 
genes, the group-specific antigen-capture ELISA, group-specific PCR, (Katz et al., 1994; MacLachlan 
et al., 1994). A serologic response in ruminants can be detected 7–14 days after infection and is 
generally lifelong after a field infection. Current recommended serologic techniques for detection of 
BTV antibody include agar gel immunodiffusion and competitive ELISA. ELISA is the test of choice 
and does not detect cross-reacting antibody to other orbiviruses, especially anti-EHDV (epizootic 
hemorrhagic disease virus) antibody (Koumbati et al., 1999). 
 
Bovine viral diarrhea virus 
History 
Bovine viral diarrhea virus (BVDV) and the very similar border disease virus (BDV) are single 
stranded RNA viruses belonging to the Pestivirus genus of the family Flaviviridae. BVDV causes 
bovine viral diarrhea (BVD), which was first reported as a transmissible disease in 1946 (Olafson et 
al., 1946). Since then, BVD has been reported worldwide and can have large economic consequences 
for farmers because of its effect on production and reproduction (OIE, 2008). BVDV virus can lead to 
a variety of clinical outcomes that range from subclinical infections to the more severe presentations 
including abortion, infertility, and the fatal mucosal disease. The condition is highly immuno-
suppressive and secondary respiratory and enteric complications often occur. There are two genotypes, 
BVDV type 1 and BVDV type 2, which are further classified as cytopathogenic (cp) or 
noncytopathogenic (ncp) based on in vitro cell culture characteristics (Brownlie J, 1990). 
Epidemiology  
Serologic surveys conducted throughout the world suggest that BVDV is endemic in the cattle 
population of most cattle-producing countries and it is considered one of the most economically 
important diseases of cattle in some parts of the world (Kampa et al., 2008). BVDV has been 
demonstrated in a number species other than cattle such as sheep, goats and alpacas (Jewett et al., 
1990, Bachofen et al., 2013, Goyal et al., 2002). Persistent infection with BVDV is documented in 
some of these species (Scherer et al., 2001, Bedenice et al., 2011, Bachofen et al., 2013) and the fact 
BVDV can infect a variety of other species that are in natural contact with cattle poses a risk for 
reinfection of pestivirus-susceptible cattle populations (Krametter-Froetscher et al., 2010). 
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Persistently infected cattle serve as a natural reservoir for virus. This form of the disease develops 
when noncytopathic BVDV is transmitted transplacentally during the first 4 months of fetal 
development. The calf is born infected with the virus and remains infected for life. These persistently 
infected animals are also usually immunotolerant to the resident noncytopathic virus. If transplacental 
infection occurs later in gestation it can result in abortion, congenital malformations, or birth of 
healthy calves that have antibody against BVDV (Houe 1999). The prevalence of persistent infection 
varies among countries and between regions within a country. According to OIE, the estimated mean 
animal prevalence of persistent infection with BVDV is ~1%–2% but may approach 4% on dairy 
farms with endemic BVDV infection (OIE 2008). Since persistently infected cattle can shed large 
amounts of BVDV in their secretions and excretions, they can easily transmit virus to susceptible 
herdmates and clinical disease and reproductive failure is often seen when healthy cattle come in 
contact with persistently infected animals. Although persistently infected cattle are important in 
transmission of BVDV, the virus may also spread by biting insects, fomites, semen and biologic 
products (OIE, 2008)(Radostitis et al. 2006). 
Clinical signs and diagnostics 
Although the name of the disease is bovine viral diarrhea, diarrhea is not a major clinical sign of 
BVDV. The clinical presentation can manifest in a variety of ways ranging from subclinical disease to 
the fatal muscosal disease. Virulence factors related to genotype and strain are partially responsible for 
these variations, together with host factors (Brownlie 1985). 
Goats and sheep 
Similar to BVD in cattle, pestivirus infections in small ruminants can cause a variety of clinical 
syndromes including reproductive failure, abortion, still birth, respiratory disease, poor growth rate, 
diarrhea, nervous signs and muscular tremor. Acute infection in immunocompetent animals usually 
causes transient mild disease followed by seroconversion, whereas infection of fetus before 
development of immune system leads to birth of persistently infected (PI) animals, which are the main 
source of transmission (Nettleton et al.1998). Historically, all pestivirus isolates from sheep and goats 
were referred as BDV. But it is now known that sheep and goats can be infected with BVDV-1, 
BVDV-2 and BDV producing similar clinical signs (Sullivan et al. 1997; Pratelli et al. 2001; Kim et 
al. 2006; Valdazo-Gonzalez et al. 2006). 
Acute infection 
Infection of immunocompetent, susceptible animals with either noncytopathic or cytopathic BVDV is 
called acute or transient BVD. The most common form of infection in the field is inapparent or 
subclinical infection without any clinical signs that is followed by seroconversion (Ames 1986). 
Typical signs of acute clinical BVD are fever, depression, decreased milk production, transient 
inappetence, rapid respiration, excessive nasal secretion, excessive lacrimation, and diarrhea. The 
clinical signs are usually seen 6–12 days after infection and last 1–3 days. Lymphoid tissue is a 
primary target for replication of BVDV, which may lead to immunosuppression and enhanced severity 
of intercurrent infections (Brownlie 1985). 
In pregnant cattle, BVDV may cross the placental barrier and infect the fetus. The consequences of 
fetal infection usually are seen several weeks to months after infection of the dam and depend on the 
stage of foetal development and on the strain of BVDV. If infection becomes established at the time of 
insemination, conception rates may be reduced, and early embryonic death is increased when the virus 
is introduced at a slightly later stage (Carlsson et al., 1989, Mc Gowan et al., 1993). Foetal infection in 
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the first trimester (50-100 days) may also result in death, although expulsion of the foetus often does 
not occur until several months later. Congenital defects can arise from transplacental infection 
between days 100 and 150. This is caused by an inappropriate inflammatory response mounted to 
BVDV by the immune system, which is undergoing the final phase of development at this stage 
(Duffell 1985).  
Persistent infection 
Fetal infection with a non-cytopathic BVDV before 120 days of gestation may result in the birth of 
persistently infected animals. At this stage in gestation, the immune system is partially competent and 
recognises the BVDV antigen as self, meaning that there is no immune response. The animal becomes 
tolerant to the virus, which persists into neonatal life (Brownlie et al., 1984). Persistently infected 
animals can be identified at birth as being antigen-positive but seronegative (Bolin et al., 1985). 
Persistently infected animals continuously shed large amounts of virus throughout their lives, 
providing a major source of infection for naive cattle (Houe 1999). Persistent infection with BVDV is 
the prerequisite for developing mucosal disease (Brownlie et al., 1984). 
Mucosal disease 
Mucosal disease is an uncommon but highly fatal form of BVD that occurs in persistently infected 
cattle between 6 and 18 months of age and can have an acute or chronic presentation (Brownlie, 
1990). Mucosal disease is induced when persistently infected cattle become superinfected with 
cytopathic BVDV. The origin of the cytopathic BVDV is usually internal, resulting from a mutation of 
the resident persistent, noncytopathic BVDV (Brownlie et al., 1984). Acute mucosal disease is 
characterized by fever, leukopenia, dysenteric diarrhea, inappetence, dehydration, erosive lesions of 
the nose and mouth and death within a few days of onset. Mucosal disease has not been observed in 
sheep or goats (Brownlie, 1985).  
Diagnostics 
BVDV and BDV antibodies can be detected in both blood and milk samples and the tests can be 
carried out on individual animals or groups of animals. The diagnosis of BVDV infection depends on 
the identification of a) virus using virus isolation, antigen ELISA, polymerase chain reaction (PCR) or 
b) evidence of exposure to virus by antibody ELISA (Brownlie et al., 2000). Antibody tests are useful 
in assessing the status of a group of animals or a whole herd prior to, or as a part of, a disease control 
programme. Tests for BVDV identify those animals that are persistently infected and should be used 
on a whole herd basis for virus eradication programmes. The only certain way of identifying a PI 
animal is by the demonstration of persisting virus. As the viraemia following acute infection (that is 
can be detected with RT-PCR) usually lasts no longer than 10 to 14 days, any animal that has a 
positive viraemia on first sampling and also at a second sampling performed a minimum of three 
weeks later, can be considered persistently viraemic. These animals usually have a low level or total 
absence of specific BVDV antibodies in both samples. (Brownlie et al., 2000) 
 
MATERIAL AND METHODS  
 
Animals and sampling  
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Blood samples and nasal swabs were collected from 238 goats and 238 sheep among 46 different 
herds in three different districts in Tanzania, during two separate field trips between June and July 
2015. The blood was collected from the animal’s jugular vein using a syringe, vacutainer, and blood 
collection tubes. One serum tube and two different nasal swabs (for PCR analysis) were collected from 
each individual. From animals that showed symptoms of PPR or its differential diagnoses 
(nasal/ocular discharge, oral lesions, diarrhea, fever or lethargia) an EDTA tube (for PCR analysis) 
and a nasal swab for bacterial analysis were also collected.  
Individuals between 3 months and one year of age were targeted, although in certain herds the small 
number of young animals made it necessary to sample older animals. The age was estimated by asking 
the owners how old the animal was. When possible, equal proportions of sheep and goats in each herd 
were sampled. The sample size was decided by calculating how many animals were necessary to 
sample to get a representative sample of each herd while at the same time sampling as many different 
herds as possible. We chose to collect samples from approximately 12-15 animals in each herd. 
However, the size of the herds varied between a couple of animals and several hundred which also had 
an impact on the number of sampled animals in each herd. During the field trips blood samples were 
stored in a plastic coolbox with cold clamps, maintaining a temperature around 5°C in the box. The 
serum was separated in the evenings and was thereafter contained in cryotubes that were also stored in 
a plastic coolbox with cold clamps. Due to field conditions and time constraints, some of the samples 
were not separated until the next day. After returning to Sokoine University all the cryotubes were 
stored in - 45 °C until serum was used for detection of antibodies. 
The areas that were sampled were chosen together with professor Gerald Misinzo from SUA. We 
chose villages in or on the borders of Selous Game Reserve (with the theory that these animals would 
have contact with wild animals) as well as villages outside Selous where animals should have less 
contact with wild animals. When this selection had been decided, a randomized selection of villages in 
these areas was done. The goal was to have two groups (with/without contact with wildlife) of a 
similar size. If a village was not possible to sample, we would instead sample the village that was 
closest geographically. We also changed our plans slightly to be able to sample some villages in 
Ulanga that had had reported outbreaks of PPR recently and that had not been sampled before.  
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Because of the limited number of samples that could be analysed with the resources at hand, a 
selection had to be made from the sampled individuals. This was done by using a randomizer. The 
analysed samples came from two different field studies, the one done during the summer of 2015 and 
the one done by master students Nica Wachtmeister, Ida Herbe and Lovisa Levin in the autumn of 
2014 (Wensman et al., 2015). The aims of the field studies were slightly different and therefor the 
selection of animals differ. During the 2014 sampling the focus was on animals of all ages, while we 
during 2015 wanted to sample animals between 3 months and 1 year of age. 
ELISA 
Enzyme-linked immunosorbent assays (ELISAs) were performed at the Genome Science Center, 
Sokoine University of Agriculture in Morogoro, to examine the presence of antibodies towards 
FMDV, BTV, BVDV and CCPP using four different ELISA kits. The number of samples that were 
analyzed varied for each disease, depending on the amount of plates available. 
CCPP 
The ELISA used for analysis of BTV was the IDEXX Mycoplasma capricolum subsp. 
capripneumoniae (Mccp) Antibody Test Kit “for the detection of antibodies directed against 
Mycoplasma capricolum subsp. capripneumoniae (Mccp) in individual caprine serum samples”. 
The competitive ELISA was performed according to the instructions of the manufacturer and all the 
samples were run once. Microplates are coated with purified Mccp lysate. Samples to be tested are 
premixed with a specific monoclonal antibody detection solution (Detection soulution Mab) in a 
separate plate (“preplate”) and then transferred into the coated microplate. Any Mccp specific 
antibodies present in the sample will form an immune-complex with Mccp antigen coated on the 
microplate, competing with Mab in the detection solution for the specific epitopes. After washing 
away unbound material, an anti-mouse antibody enzyme conjugate that binds the Mab in the Detection 
solution is added. In the presence of immune-complexes between Mccp antigen and antibodies from 
the sample, the Mab cannot bind to the specific epitopes and the conjugate is therefore prevented from 
binding. Conversely in the absence of Mccp-antibodies in the test sample, the Mab can bind to its 
Figure 3. Sampling in Ulanga. Photo: Nils Roos.                              Figure 4. Laboratory work. 
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specific epitopes and the conjugate is free to bind to it. Unbound conjugate is washed away and an 
enzyme substrate (TMB) is added. In presence of the enzyme, the substrate is oxidized and develops a 
blue compound becoming yellow after blocking. Subsequent color development is inversely 
proportional to the amount of anti-Mccp antibodies in the test sample. The result is expressed in 
“percentage of inhibition” by comparing the optical density in the test well with the optical densities in 
the Mab Control wells. 
To control the validity of each plate, the conjugate control mean absorbance (CCX) and Mab control 
mean absorbance (MabCX) were calculated. The Percentage of Inhibition (S PI) for each sample and 
control was calculated by dividing (S PI = 100x (MabCX – S A(450))/ MabCX – CCX). The plate was 
considered valid when the following criteria were met (PI = Percentage of inhibition, PC = Positive 
control, NC = Negative control): 
If the sample value was less than 55%, the sample was considered negative. Samples with S PI% 
greater than or equal to 55% were considered positive. 
Table 1: Distribution of the 343 samples analysed by the CCPP-ELISA. The percentage shows the 
percentage of the sampled individuals that were analysed. 
Goats n Sheep n Total analyzed n Contact with wildlife n 
Kilombero 183 (89%) 54 (78%) 237 (86%) 80 (100%) 
Ulanga (2015) 40 (33%) 42 (50%) 82 (40%) 97 (100%) 
Mvomero 13 (15%) 11 (13%) 24 (14%) 24 (14%) 
Total analyzed 236 (49%) 107 (33%) 343 (43%) 177 (75%) 
FMDV 
The ELISA used was an ID. Vet Screen competitive ELISA for ”the detection of anti-FMDV non-
structural protein antibodies in serum and plasma from bovine, ovine, caprine, porcine and all 
susceptible species”. The competitive ELISA was performed according to the instructions of the 
manufacturer and all the samples were run once. Microwells are coated with the non-structural protein 
of the Foot and mouth disease virus (FMDV NSP). Samples to be tested and controls are added to the 
microwells. Anti-NSP antibodies, if present, form an antigen-antibody complex which masks the virus 
epitopes. An anti-NSP horseradish peroxidase (HRP) conjugate is added to the wells, which fixes the 
remaining free epitopes, forming an antigen-conjugate-HRP-complex. The excess conjugate is 
removed by washing, and the substrate solution (TMB) is added. The resulting coloration depends on 
the quantity of specific antibodies present in the sample to be tested; in the absence of antibodies a 
blue solution appears which becomes yellow after addition of the stop solution, and in the presence of 
          0.500 ≤ MabCX ≥ 2.000          CCX < 0.300 
Mean NC PI ≤ 35%         50% ≤ Mean PC PI ≤ 80%       60% ≤ Mean SPC PI ≤ 90% 
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antibodies no coloration appears (ID Screen® FMD NSP Competition manual, 2014). The plate is 
read at 450 nm. 
To control the validity of each plate, the mean value of the two negative controls (ODNC) was 
calculated and the plate was considered valid when ODNC > 0.7 and the mean value of the two positive 
controls divided by ODNC was < 0.3. For each sample the competition percentage (S/N %) was 
calculated by dividing (ODsample/ODNC) x 100. If the value was equal or less than 50 % the sample was 
considered positive while a value greater than 50 % was a negative result. 
Table 2: Distribution of the 805 samples analysed by the FMDV-ELISA. The percentage shows the 
percentage of the sampled individuals that were analysed. 
 
 
Goats n Sheep n Total analyzed n Contact with wildlife n 
Kilombero 205 (100%) 69 (100%) 274 (100%) 80 (100%) 
Ulanga (2015) 123 (100%) 84 (100%) 207 (100%) 97 (100%) 
Mvomero 89 (100%) 87 (100%) 176 (100%) 176 (100%) 
Ulanga (2014) 61 (100%) 87 (100%) 149 (100%) 149 (100%) 
Total analyzed 478 (100%) 327 (100%) 805 (100%) 177 (100%) 
 
BTV 
The ELISA used for analysis of BTV was the IDEXX Bluetongue Virus (BTV) Antibody Test Kit “for 
the detection of antibodies directed against VP7 protein from Bluetongue Virus (BTV) in individual 
serum and plasma samples from bovine, ovine and caprine origin”. There are 27 known serotypes of 
BTV; among BTV viral proteins, VP7 is common to all known serotypes, strongly immunogen and 
specific to BTV. 
The competitive ELISA was performed according to the instructions of the manufacturer and all the 
samples were run once. The wells of the microplate are coated with recombinant VP7 protein. 
Samples to be tested are diluted and incubated in the wells. Any antibody specific to VP7 present in 
the samples will form an antigen-antibody immune-complex. After incubation, an anti-VP7 antibody 
coupled to the peroxidase is added in the wells. If the sample contains specific VP7 antibodies, the 
VP7 sites are "masked" and the conjugate cannot bind on the corresponding epitope. After washing, 
the enzyme substrate (TMB) is added to the conjugate, forming a blue compound becoming yellow 
after blocking. The intensity of the colour is an inverse measure of the proportion of anti-VP7 
antibodies present in the sample to test (IDEXX Bluetongue Competition manual, 2015). The plate is 
read at 450 nm. 
To control the validity of each plate, the mean value of the two negative controls (ODNC) was 
calculated and the plate was considered valid when 0.700 ≥ ODNC ≤ 0.3000 and the competition 
percentage (S/N %) of the positive control was < 20%. For each sample the competition percentage 
(S/N %) was calculated by dividing (ODsample/ODNC) x 100. If the value was equal or greater than 80%, 
the sample was considered negative. A value greater than 70% and less than 80% was considered a 
doubtful result. Samples with S/N% less than or equal to 70% were considered positive. 
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Table 3: Distribution of the 455 samples analysed by the BTV-ELISA. The percentage shows the 
percentage of the sampled individuals that were analysed. 
 
 
Goats n Sheep n Total analyzed n Contact with wildlife n 
Kilombero 155 (76%) 42 (61%) 197 (72%) 80 (100%) 
Ulanga (2015)  103 (84%) 54 (64%) 157 (76%) 68 (70%) 
Mvomero  28 (31%) 37 (43%) 65 (37%) 65 (37%) 
Ulanga (2014)  13 (21%) 23 (26%) 36 (24%) 36 (24%) 
Total analyzed 299 (63%) 156 (48%) 455 (57%) 249 (50%) 
 
BVDV 
The ELISA used for analysis of BVDV was the IDEXX BVDV p80 Ab Test Kit “for the detection of 
antibodies directed against p80 protein for diagnostic of BVDV and Mucosal disease (MD) in 
individual serum, plasma and milk samples and in pools of serum (maximum 10) and tank milk 
samples from bovine origin and for diagnostic of Border Disease (BD) in individual serum and plasma 
samples and pools of serum samples (maximum 5) from sheep”. It is based on the principle of 
competition between antibodies and a Peroxidase coupled monoclonal anti-p80-antibody “WB112”. 
The competitive ELISA was performed according to the instructions of the manufacturer and all the 
samples were run once. The P80 protein is supplied coated on wells of the polystyrene microplate by 
means of a specific monoclonal antibody “WB103”. Samples to be tested are diluted and incubated in 
the wells. If specific antibodies are present in the sample, they form bovine (or ovine) antibody-P80 
complexes, through which the P80 becomes "masked". After washing, a monoclonal antibody 
“WB112” (directed to another epitope of P80) coupled to the enzyme peroxidase is incubated in the 
wells. In presence of specific BVDV antibodies in the sample, the P80 protein sites are "masked", and 
the conjugate cannot bind on the corresponding epitope. After washing, the enzyme substrate (TMB) 
is added to the wells. If the conjugate is fixed in the wells, it transforms the substrate into a blue 
compound becoming yellow after the blocking. The intensity of the colour is an inverse measure of the 
rate of anti-p80 antibodies present in the sample to test (IDEXX BVDV p80 Ab manual, 2015). The 
plate is read at 450 nm. 
To control the validity of each plate, the mean value of the two negative controls (ODNC) was 
calculated and the plate was considered valid when ODNC ≥ 0.8000 and the competition percentage 
(S/N %) of the positive control was < 20%. For each sample the competition percentage (S/N %) was 
calculated by dividing (ODsample/ODNC) x 100. If the value was equal or greater than 50%, the sample 
was considered negative. A value greater than 40% and less than 50% was considered a doubtful 
result. Samples with S/N% less than or equal to 40% were considered positive. 
Table 4: Distribution of the 478 samples analysed by the BVDV-ELISA. The percentage shows the 
percentage of the sampled individuals that were analysed. 
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Goats n Sheep n Total analyzed n Contact with wildlife n 
Kilombero 160 (78%) 48 (70%) 208 (76%) 80 (100%) 
Ulanga (2015) 99 (80%) 65 (77%) 164 (79%) 61 (63%) 
Mvomero 33 (37%) 36 (41%) 70 (40%) 70 (40%) 
Ulanga (2014) 13 (21%) 23 (26%)  36 (24%) 36 (24%) 
Total analyzed 306 (64%) 172 (52.6) 478 (59.4) 141 (80%) 
 
Questionnaire  
At the sampling missions a sample submission form/questionnaire was used to gather basic 
epidemiological data of the herds. The questions were asked to each livestock keeper through an 
interpreter that most of the time was the local veterinarian or the assistant of the veterinarian. The 
questions were as following:  
1. Amount of animal interaction with wildlife?  
2. Latest introductions of new animals to herd? 
3. Last vaccination of herd against PPR/CCPP/FMD? 
4. Last de-worming of herd? 4b. all animals treated? 
5. Last antibiotic treatment of herd? 5b. all animals treated? 
6. Estimated date when first PPR case was observed at this farm? 
7. Details of animals (number of sick and dead animals since the start of the outbreak, age of 
animals, number of goats/sheep) 
8. Type of farming? (Household/Dairy production/Meat production/Individual seller at live 
animal market/Other) 
9. Clinical signs of outbreak? (Abortion/Diarrhea/Pneumonia/Oral mucosal lesions/Nasal and 
ocular discharges/High temperature/Other) 
 
 
RESULTS 
 
Seroprevalence of CCPP 
In total, 343 individuals from three different areas were screened for antibodies against CCPP. The 
animals came from 43 herds in the districts Kilombero, Ulanga (2015) and Mvomero. Out of the 43 
herds, 17 herds had at least one seropositive animal. The herd-prevalence varied between 8%-100%. 
However, in some of the herds with 100% herd-prevalence only one animal was analysed. Of the 17 
herds in Ulanga, 16 had been vaccinated against CCPP sometime between 2012 and 2014. No herds in 
Kilombero had been vaccinated. The owners in Mvomero were not asked if their animals had been 
vaccinated against CCPP. Two of the ELISA-plates were considered invalid and therefore the number 
of samples that were analysed were fewer than expected. 
17 
 
Table 5: Results from CCPP-ELISA showing the total seroprevalence and number of positive animals. 
In total 343 individuals were analysed. 
 
 
Goats % (n) Sheep % (n) Total % (n) Contact with wildlife (n) 
Kilombero 32.2 (59) 5.5 (3) 26.2 (62) 6.2 (5) 
Ulanga (2015) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 
Mvomero 23.0 (3) 0.0 (0) 12.3 (3) 12.3 (3) 
Total % 26.2 (62) 2.8 (3) 19.0 (65) 2.3 (8) 
 
Of the 343 analysed samples totally 65 individuals were considered positive (Table 5). Using the 
equation 𝑝 =  ±1,96 √
𝑝(1−𝑝)
√𝑛
 to calculate a 95% confidence interval for the proportion gives that the 
total seroprevalence of CCPP can be said with 95% confidence to lie between 15% and 23%. 
Kilombero had the highest seroprevalence of the sampled areas with between 27% and 37% 
seroprevalence. The same area also had the highest seroprevalence among the herds. The 
seroprevalence was lowest in Ulanga district were none of the analysed samples were considered 
positive. As previously stated, the vast majority of the animals in Ulanga district were vaccinated 
against CCPP. 
In Kilombero the seroprevalence in the herds who had contact with wildlife was with 95% confidence 
between 1,2% and 3,4% which is much lower compared to the total seroprevalence. The 
seroprevalence in goats was also than in sheep in both Kilombero and Mvomero. However, it is 
possible that this might be more related to the fact that the herds with high prevalence happened to 
consist of only goats. 
 
Seroprevalence of FMDV 
Serum from 805 individuals from four different areas was analysed for antibodies against FMDV. The 
animals came from 71 different herds and 40 of these herds had at least one seropositive animal. The 
herd-prevalence varied between 7%-91%. None of the herds had been vaccinated against FMD. 
Table 6: Results from FMDV-ELISA showing the total seroprevalence and number of positive animals. 
In total 805 individuals were analysed. 
 
 
Goats % (n) Sheep % (n) Total % (n) Contact with wildlife (n) 
Kilombero 20.5 (42) 14.5 (10) 18.0 (52) 5.0 (4) 
Ulanga (2015) 18.7 (23) 6.0 (5) 13.5 (28) 10.3 (10) 
Mvomero 67.4 (60) 67.8 (59) 67.6 (119) 67.6 (119) 
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Ulanga (2014) 13.1 (8) 6.9 (6) 9.4 (14) 9.4 (14) 
Total % 27.8 (133) 24.5 (80) 26.5 (213) 7.9 (14) 
 
Of the 805 analysed samples totally 213 individuals were considered positive (Table 6). Using the 
equation 𝑝 =  ±1,96 √
𝑝(1−𝑝)
√𝑛
 to calculate a 95% confidence interval for the proportion gives that the 
total seroprevalence of FMDV can be said with 95% confidence to lie between 24% and 29%. 
Mvomero had the highest seroprevalence of the sampled districts with between 65% and 71% 
seroprevalence. The same area also had the highest seroprevalence among the herds, with one herd 
where 91% (10 out of 11 animals) of the sampled individuals were seropositive. The seroprevalence 
was lowest in Ulanga (2014) were between 7,2% and 11% of the animals were considered positive 
with 95% confidence.  
The total seroprevalence among the herds with contact with wildlife was with 95% confidence 
between 6,0% and 9,7% which is lower than the total seroprevalence. 
 
Seroprevalence of BTV 
In total, 455 individuals from four different districts were screened for antibodies against BTV. The 
animals came from the same 71 herds that were analysed for FMDV. Out of these 71 herds, 69 herds 
had at least one seropositive animal. The herd-prevalence varied between 8%-100%. We did not ask 
the livestock keepers if they had vaccinated their animals against BTV. 
Of the 455 analysed samples totally 305 individuals were considered positive (Table 7) and using the 
equation 𝑝 =  ±1,96 √
𝑝(1−𝑝)
√𝑛
 to calculate a 95% confidence interval for the proportion the total 
seroprevalence of BTV can be said with 95% confidence to lie between 63% and 71%. 
Table 7: Results from BTV-ELISA showing the total seroprevalence and number of positive animals. 
In total 455 individuals were analysed. 
 
 
Goats % (n) Sheep % (n) Doubtful % (n) Total % (n) Contact with 
wildlife (n) 
Kilombero 
 
60.1 (94) 54.8 (23) 4.0 (8) 59.4 (117) 61.3 (49) 
Ulanga (2015) 74.8 (77) 53.7 (29) 5.0 (8) 67.5 (106) 63,2 (43) 
Mvomero 85.7 (24) 83.8 (31) 3.0 (2) 84.6 (55) 84.6 (55) 
Mahenge 76.9 (10) 73.9 (17) 4.3 (3) 75.0 (27) 75.0 (27) 
Total % 68.6 (205) 64.1 (100) 4.6 (21) 67.0 (305) 69.9 (174) 
Mvomero had the highest seroprevalence of the sampled areas. With a confidential interval of 95% the 
seroprevalence in Mvomero was between 82% and 88%. The same area also had the highest 
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seroprevalence among the herds and in 6 of the 12 sampled herds all individuals were seropositive. 
The seroprevalence was lowest in Kilombero district were the total seroprevalence was between 55% 
and 64% with 95% confidential interval.  
The total seroprevalence in the herds who had contact with wildlife was only slightly higher (between 
66% and 74%) compared to the total seroprevalence. In Mvomero and Ulanga (2014) all sampled 
animals had contact with wildlife and the total seroprevalence in these two regions was higher than in 
Kilombero and Ulanga.  
 
Seroprevalence of BVDV 
Serum samples from 478 individuals from four different areas were analysed for antibodies against 
BVDV. The animals came from 68 different herds and 7 of these herds had at least one seropositive 
animal. In one herd in Mvomero, 4 out of 4 sampled animals were seropositive. The herd-prevalence 
varied between 7%-100% but in most of the positive herds the herd-prevalence was around 20%. We 
did not ask the livestock keepers if they had vaccinated their animals against BVDV. 
Of the 478 analysed samples totally 14 individuals were considered positive (Table 8). Using the 
equation 𝑝 =  ±1,96 √
𝑝(1−𝑝)
√𝑛
 to calculate a 95% confidence interval for the proportion gives that the 
total seroprevalence of BVDV can be said with 95% confidence to lie between 1,3% and 4,5% 
Mvomero had the highest seroprevalence of the sampled areas. With 95% confidence the 
seroprevalence in Mvomero was between 4,7% and 9,5%. The same area also had the highest 
seroprevalence among the herds. The seroprevalence was lowest in Ulanga district were none of the 
analysed samples from 2014 were considered positive. It is worth noting that only a small number of 
samples (36) were analysed from Ulanga.  
Table 8: Results from BVDV-ELISA showing the total seroprevalence and number of positive animals. 
In total 478 individuals were analysed. 
 
 
Goats % (n) Sheep % (n) Doubtful % (n) Total % (n) Contact with 
wildlife (n) 
Kilombero 0.0 (0) 2.0 (1) 0.9 (2) 0.5 (1) 0.0 (0) 
Ulanga (2015) 5.0 (5) 4.6 (3) 2.4 (4) 4.9 (8) 13.1 (8) 
Mvomero 9.0 (3) 5.6 (2) 1.4 (1) 7.1 (5) 7.1 (5) 
Ulanga (2014) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 
Total % 2.6 (8) 3.5 (6) 1,5 (7) 2.9 (14) 9.2 (8) 
 
The total seroprevalence in the herds who had contact with wildlife, with 95% confidence between 
6,6% and 11,8%, was higher than the total seroprevalence of all sampled animals.  
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DISCUSSION 
The aim of this study was to do a serological screening of some of the diseases which can cause 
similar signs (FMD, BTV, BVDV and CCPP) of PPR among sheep and goats in southern Tanzania. 
The results show that all of these diseases are circulating and endemic in the area, assuming the results 
in the study represents the true prevalence in southern Tanzania. Therefore, these diseases are relevant 
in PPR differential diagnosis and need to be taken into consideration when planning the surveillance 
and control of PPR. 
The seroprevalence differed highly between diseases. BTV had the highest seroprevalence with a total 
seroprevalence of between 63% and 71%, while BVDV had the lowest with a total seroprevalence of 
between 1,3% and 4,5%. The total seroprevalence of FMD and CCPP was between 24%-29% and 
15%-23% respectively.  
Although the aim was to get a representative sample of animals from the different districts, it is 
possible that the way animals were selected for sampling and analyses might have contributed to 
selection bias. The analysed samples came from two different field studies, the one done during the 
summer of 2015 and one done by master students Nica Wachtmeister, Ida Herbe and Lovisa Levin in 
the autumn of 2014. The aims of the two field studies were slightly different and therefore the 
selection of animals differs. During the 2014 sampling the focus was on older individuals while we 
during 2015 wanted targeted animals between 3 months and 1 year of age. For this reason, the 
sampled animals from Mvomero and Ulanga (2014) were generally older than the animals from 
Kilombero and Ulanga (2015). It is therefore possible that the higher seroprevalence of BTV in 
Mvomero and Ulanga (2014) can be attributed to the fact that the sampled individuals had had a 
longer time to possibly come in contact with the disease. In retrospect, I should perhaps have chosen 
to analyse samples from only the young individuals from Mvomero and Ulanga (2014) as well. 
During the 2015 sampling we targeted herds in Ulanga that had had recently reported outbreaks of 
PPR to have a higher chance of finding individuals that were PCR-positive for PPRV. We were not 
told of any recent outbreaks in the other districts. We were also very dependent on our assistants in the 
different districts, who were the ones in contact with the farmers and who had a large impact on which 
herds were selected for sampling within the area. The sampling could in some instances be quite 
chaotic with a large number of people and animals involved, and therefore it is possible that some of 
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the information about the animals is not correct. While sampling animals, the owner were asked to 
give an approximate age of the animal and while some owners were very precise, it is likely that some 
of the ages are only a vague estimation. It is also difficult to know how much we can trust the 
information regarding vaccinations as some farmer were unsure about exactly when and against what 
their animals had been vaccinated. 
The aim was to analyse individuals from as many herds as possible, as we thought that would be a 
better indication of prevalence rather than analysing a large number of individuals from the same herd. 
Because of unforeseen difficulties such as power breaks, some ELISA-plates were not usable and 
therefor the number of analysed samples in some cases were smaller than anticipated which resulted in 
only one individual being analysed in some herds. 
CCPP 
Of the 343 analysed samples totally 65 individuals were considered positive and the total 
seroprevalence was between 15% and 23% with 95% confidence. It is worth noting that the 
seroprevalence was 0.0% in Ulanga where 16 of the 17 sampled herds had been vaccinated against 
CCPP sometime between 2012 and 2014. The reason we found no seropositive animals, even though 
the herds had been vaccinated, might be that we targeted animals younger than 1 year, who would not 
have been alive during the recent vaccinations. Unfortunately, we do not know what vaccine was used 
and why the animals were vaccinated. According to OIE guidelines, CCPP vaccine efficacy should 
last at least 1 year and protect vaccinated animals from clinical disease. There are currently no CCPP 
vaccines permitting a DIVA (detection of infection in vaccinated animals) strategy. From this we can 
draw the conclusion that the vaccinations in this area seem to have protected the animals from 
outbreaks of CCPP. The latest vaccination we were told of occurred in 2014, and therefore it is also 
possible that the amount of antibodies had declined enough for the animals to be considered 
seronegative. 
A previous study on seroprevalence of CCPP among goats and sheep in the two districts Lindi and 
Mtwara in southern Tanzania was done in 2014. The overall seroprevalences in the two districts were 
35.5% in goats and 22.9% in sheep (Mbyuzi et al., 2014). In the study by Mbyuzi et al. there was also 
a great variation of the seroprevalence in sheep between studied districts, with the highest being 62.5% 
in Tandahimba and the lowest being 22.2% in Masasi, both in Mtwara region. It was further evident 
that seroconversion rates were significantly higher in the government farms than in traditional flocks. 
The authors explained that the high seropositivity of CCPP in government farms, as opposed to the 
observed low seroprevalence of CCPP in the traditional flocks, could possibly be because of the 
difference in available animal health services between the two systems of animal husbandry. 
Government farms often have better access to disease management which leads to more animals being 
treated when sick which in turn allows high recovery rates of affected animals as opposed to high case 
fatality rates observed in traditional flocks as a result of poor access to animal health services (Mbyuzi 
et al., 2014). Other authors (El Hassan et al., 1984, Thiaucourt and Bölske, 1996 and Wesonga et al., 
2004) have reported high carrier status for animals recovering from CCPP following antibiotic 
treatment, which could be linked to the high seroprevalence of CCPP in government farms. In this 
study, the seroprevalence in the herds in Kilombero who had contact with wildlife was much lower 
compared to the total seroprevalence. This might be explained by the theory above, as the herds in 
contact with wildlife are mainly traditional flocks. The seroprevalence in goats was also much higher 
than in sheep in both Kilombero and Mvomero. It is possible that this is simply because the herds with 
high prevalence happened to consist of only goats and therefore no sheep were sampled. However, the 
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seroprevalence in goats was also higher compared to sheep in the 2014 study by Mbyuzi et al. and 
these results may support the theory that goats are more susceptible to CCPP than sheep. 
Comparing my results to previous studies, I believe my results are credible. Because CCPP can cause 
similar signs in goats and sheep as PPRV and appears to be present in the study area, it is a relevant 
differential diagnosis of animals with suspected PPR in southern Tanzania. 
FMDV 
Of the 805 samples analysed for FMDV, totally 213 individuals were considered positive and the total 
seroprevalence was between 24% and 29% with 95% confidence. None of the analysed individuals 
had been reported as vaccinated which indicates that they have been exposed to natural infection of 
FMDV. The seroprevalence was slightly lower among the animals with contact with wild animals. It is 
difficult to say why this is since wildlife is considered a possible source of infection. It is possible that 
because the animals that have contact wild wildlife were mainly livestock belonging to Maasai people, 
the fact that they are rarely brought to live animal markets and generally have a larger area to graze on 
make them less likely to contract the disease from domestic animals and that it is this factor rather than 
the contact with wildlife that results in a lower prevalence among these animals. 
FMD is considered endemic in Tanzania although the spatio-temporal distribution of FMD virus has 
not been clearly investigated. Previous studies of seroprevalence of FMDV in cattle in several districts 
have shown seroprevalence ranging between 81% (Bagamoyo district) and 15.4% (Temeke) (Joseph J. 
et al., 2014). I have not found any FMDV seroprevalence studies among small ruminants in Tanzania. 
However, a study in Uganda from 2009 show a seroprevalence of 14% in goats and 22% in sheep in 
one district, while some of the other districts included in the same study had seroprevalences between 
0%-100% (Balinda et al., 2009). Studies in Morocco following an FMD outbreak in 1999 identified a 
prevalence of 13% among sheep (Blanco et al., 2002). In contrast, an earlier Kenyan study showed 
high antibody prevalences of 89% (type O) and 56% (SAT 2) in small ruminants (Anderson et al., 
1976). Antibodies towards FMDV have been shown to decline faster in small ruminants than in cattle 
(Dellers and Hyde, 1964; Cunliffe, 1964; Garland, 1974) although limited earlier studies have shown 
that antibodies in sheep, despite a slight decrease after day 10, remain relatively high for at least 
147 days (Dellers and Hyde, 1964). It is obvious that the seroprevalence is very varied among districts 
and even herds in the same district. Comparing my results to previous studies, I believe my results are 
credible as they are similar to those in previous studies. Because FMDV can cause similar signs in 
goats and sheep as PPRV and appears to be present in the study area, it is a relevant differential 
diagnosis of animals with suspected PPR in southern Tanzania. 
BTV 
Of the 455 samples screened for BTV, a total of 305 individuals were considered positive and the total 
seroprevalence was between 63% and 71% with 95% confidence. The total seroprevalence was higher 
in Mvomero and Ulanga (2014) than in Kilombero and Ulanga (2015). The seroprevalence in goats 
was higher than in sheep in all areas. Because the sampled animals from Mvomero and Ulanga were 
generally older than the animals from Kilombero and Ulanga (2015), it is possible that the higher 
seroprevalence of BTV in Mvomero and Ulanga (2014) can be attributed to the fact that the sampled 
individuals had had a longer time to possibly come in contact with the disease. However, this pattern 
could be seen in the seroprevalence of the other diseases in this study and the seroprevalence in 
Mvomero and Ulanga (2014) might actually be higher than in the other two regions. It is also possible 
that the disease is more prevalent in some areas compared to others due to climate, which might affect 
the amount of vectors in the area.   
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Bluetongue is considered endemic in Tanzania although very few serological studies on goats and 
sheep appear to have been done. In one study conducted in northern Tanzania in 1995, a 
seroprevalence of 74% in sheep and 77% in goats was demonstrated (Hyera and Lyary, 1995). It is 
interesting to note that this study showed a higher prevalence among older individuals and a slightly 
higher prevalence in goats compared to sheep. Studies done on wildlife showed that there was a high 
prevalence of antibodies against BT virus in buffalo, wildebeest kongoni, topi, waterbuck and impala 
which supports the suggestion that these species probably act as maintenance hosts (Hamblin et al., 
1990). 
A seroprevalence of 67% is similar to that in previous published studies (Hyera and Lyary, 1995). No 
vaccination programme against BT virus in sheep or goats is in practice in Tanzania and the antibodies 
in the sera of the sampled animals must have arisen as a consequence of either natural infection with 
the virus or of passive immunization with maternal antibodies. Clinical BT is generally seen amongst 
wool sheep and their crosses with native hair sheep (Hyera and Lyary, 1995). Hair sheep show 
evidence of challenge by BT but clinical manifestation of the disease has not been encountered. 
Almost 100% of the Tanzanian sheep population is native hair type. Consequently, clinical BT does 
not seem to occur in Tanzania (Hyera and Lyary, 1995).  
It is not surprising that BTV infection occurs in Tanzania, but studies are needed to increase the 
knowledge about the epidemiology and pathogenesis of BTV among different animal populations, in 
particular domestic and wild ruminants in Tanzania. However, the chances of mistaking PPR for BT 
and vice versa appear very low at the moment considering that BT does not seem to cause any clinical 
signs in Tanzanian sheep and goat breeds. 
BVDV 
Of the 478 samples analysed for BVDV or BDV totally 14 individuals were considered positive and 
the total seroprevalence was between 1,3% and 4,5% with 95% confidence. This was by far the lowest 
total seroprevalence among the studied diseases. We did not ask the livestock keepers if their animals 
had been vaccinated against BVDV but it seems unlikely that the animals were vaccinated and 
therefore the antibodies in the sera of the sampled animals can be assumed to be because of natural 
infection with BVDV. The total seroprevalence was higher among the animals who had contact with 
wildlife compared to those who did not. The total seroprevalence in sheep was also slightly higher 
than in goats. 
I have only been able to find one previous serological study of BVDV in goats and sheep in Tanzania, 
done by Hyera, Liess and Frey in 1991. This study showed that sheep and goats in northern Tanzania 
had seemingly been exposed to BVD virus. The study was done using a direct neutralising peroxidase-
linked antibody (NPLA) assay and the seroprevalence was considered 32.1% in sheep and 24.9% in 
goats. The authors concluded that BVD virus possibly cycles within the cattle population in Tanzania 
and should be taken into consideration as a possible cause of death, abortion, weak and/or malformed 
offspring among and possibly also among sheep and goats (Hyera et al., 1991). 
There has also been one study done on antibodies to BVDV in free-living buffalo in Tanzania. The 
number of seropositive buffalos varied considerably between different areas, with the highest 
seroprevalence being 71.9% in north Serengeti while no positive samples were found in several other 
areas (Hamblin et al., 1990). 
It is difficult to draw any conclusions regarding my results from these previous studies. The 
seroprevalence in this study was much lower compared to the seroprevalence recorded by Hyera, Liess 
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and Frey in 1991. However, they used NPLA technique while I used a competitive ELISA technique 
for detection of antibodies. It is possible that their method was more sensitive. The study from 1991 
was also done in northern Tanzania while this study was done in the south eastern part of the country. 
It is definitely possible that the prevalence varies between these regions. This observation together 
with the large difference in herd-prevalence possibly suggests the virus is only circulating within 
defined areas in Tanzania. Cattle, goats and sheep are often managed together in Tanzania and the first 
two species form the commonest group association. At night sheep and goats are kept together while 
cattle are held in separate enclosures. It is possible that an exchange of diseases such as BVDV occurs 
between cattle and sheep when the two species graze together. Goats on the contrary, prefer to browse 
on shrubs and bushes and are therefore less likely to be in close contact with cattle or sheep during the 
day and it is probable that they pick up BVDV mainly at night from infected sheep and at watering 
points where they come into close contact with infected cattle or sheep. This might explain the higher 
seroprevalence among sheep compared to goats in both this study and the study by Hyera, Liess and 
Frey in 1991.  
BVDV is prevalent in buffalo, which suggest that wildlife is involved in the circulation and spread of 
the disease. To further understand the epidemiology and prevalence of BVDV in Tanzania, further 
specific virological and serological investigations should be made. Because BVDV can affect 
outbreaks of PPRV and other diseases due to immunosuppression and appears to be present in the 
study area, it is a relevant diagnosis to consider when investigating animals with suspected PPR in 
southern Tanzania. 
 
Conclusions 
This study has showed that FMD, BT, BVD and CCPP are serologically present in southern Tanzania 
where wild and domestic small ruminants intermingle. The importance of the different diseases varies 
because of the differing levels of severity and consequences for farmers. In my opinion, FMDV and 
CCPP are relevant differential diagnoses to PPR that should be taken into consideration when working 
to prevent, and in longer term, eradicate PPR. The risk of mistaking PPR for BT and vice versa appear 
very low at the moment considering these diseases do not appear to cause similar clinical signs to PPR 
in Tanzanian sheep and goats. As mentioned above, because BVDV can affect outbreaks of PPRV and 
other diseases due to immunosuppression and appears to be present in the study area, it is a relevant 
diagnosis to consider when investigating animals with suspected PPR in southern Tanzania. 
The epidemiology, socio-economic impact and possible ways of preventing these diseases are very 
complicated and it is of great interest and importance to further evaluate the prevalence of PPRV and 
its differential diagnoses in different parts of Tanzania. By doing this the international community 
have a higher possibility of 1) stopping the rapid spread of disease to other regions 2) decreasing the 
economic, food security and livelihood impacts these diseases have because of the key role sheep and 
goats play in national food and nutritional security, income security and livelihood resilience in the 
least economically developed countries across the world  and 3) sustaining the momentum created by 
the eradication of rinderpest that  resulted in a growing interest among the international community to 
address PPR at a regional and global scale. 
I hope that this thesis and the data collected during this project will contribute to the understanding 
and prevention of spread of PPR and the studied diseases, which in turn will hopefully enable 
prosperous livestock production and more effectively integrated conservation of wildlife, to the benefit 
of both animals and people. 
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